RedCloud Addresses Systemic Inefficiencies in FMCG Products Supply Chain with Launch of Bulk Trading Program
Globenewswire· 2025-06-26 20:00
New York, NY, June 26, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (“RCT”) (“RedCloud” or the “Company”) today announced the launch and availability of its innovative TradeX program, facilitating the trade of essential FMCG products in bulk quantities, matching market supply with demand across key categories. Emerging markets face systemic inefficiencies in retail commerce, resulting in a staggering approximately $2 trillion inventory gap1 where consumer demand often outpaces product availability in su ...
OSS Announces Third Order from Leading Asian Defense Contractor for Autonomous Maritime Application
Globenewswire· 2025-06-26 20:00
OSS expects approximately $4 million in cumulative new orders over the next several years as current customer expands production of unmanned surface vehicles for harbor patrol applicationsESCONDIDO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced it has received a third order from a leading defense cont ...
Hyperscale Data Highlights AI Infrastructure Growth and Corporate Transition in Stockholder Letter
Globenewswire· 2025-06-26 20:00
Hyperscale Data Sees Growth Opportunity and Undervalued Asset in Michigan Data Center, which Has the Potential to Expand to 340 MWLAS VEGAS, June 26, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today issued the following letter to its stockholders from its Founder and Executive Chairman, Milton “Todd” Ault III. Dear Stockholders, As the Founder and Executive Chairman of Hyperscale Data, I want to share important up ...
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
Globenewswire· 2025-06-26 20:00
KNOXVILLE, Tenn., June 26, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of preclinical research by Christine Chung, MD and her team (the “Chung Lab”) at Moffitt Cancer Center in Tampa, Florida (“Moffitt”), evaluating intratumoral PV-10 in models of head and neck squamous cell carcinoma (“HNSCC”). The study, published in Molecular Cancer Therapeutics, highlights novel mechanistic findings that could support future cli ...
Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing
Globenewswire· 2025-06-26 20:00
SOLANA BEACH, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today announced it has entered into a definitive securities purchase agreement for an At-the-Market private placement for gross proceeds of approximately $1.425 million. Under the terms of the agreement, Artelo will issue 136, ...
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
Globenewswire· 2025-06-26 20:00
文章核心观点 蒙托克酿酒公司与高端生活方式品牌法赫蒂合作推出限量版啤酒和海滨风格服装系列,庆祝蒙托克酿酒13周年,体现两个品牌对海岸生活的热爱,还将与冲浪者基金会合作举办海滩清理和庆祝活动 [1][2][6] 合作项目 - 推出限量版啤酒“Après Surf Beer”,是蒙托克“Surf Beer Golden Ale”的热带版,有菠萝和椰子味 [2] - 推出限量版服装系列,印有蒙托克酿酒标志,包含法赫蒂标志性单品 [2] - 限量版啤酒仅在纽约蒙托克的蒙托克啤酒谷仓销售,服装系列在www.montaukbrewingco.com网站上发售 [7] 合作意义 - 蒙托克酿酒公司联合创始人表示,双方都认为优质啤酒和时尚是一种体验,此次合作体现了这一愿景,庆祝两个品牌与海岸生活的联系 [4] - 法赫蒂联合创始人称,此次合作契合品牌激励人们充实生活的宗旨,能融入东长岛冲浪文化和社区,加强与当地消费者的联系 [5][6] 合作活动 - 与冲浪者基金会东长岛分会合作,于6月28日举办海滩清理活动,随后在啤酒谷仓庆祝蒙托克酿酒13年历程 [6] 公司介绍 蒙托克酿酒公司 - 2012年由好友创立,秉持“做自己”的座右铭,在东端酿造优质啤酒,其红色啤酒谷仓位于蒙托克市中心,全年开放 [8] - 官网为www.montaukbrewco.com,社交媒体账号为@montaukbrewco [9] 蒂雷公司 - 是全球领先的生活方式和消费品包装公司,业务覆盖加拿大、美国、欧洲、澳大利亚和拉丁美洲,在大麻、饮料、健康和娱乐领域具有变革性影响力 [10] - 使命是成为领先的高端生活方式公司,旗下拥有40多个品牌,产品涵盖大麻、 hemp 食品和精酿饮料 [10] - 官网为Tilray.com,社交媒体账号为@Tilray [11] 法赫蒂 - 2013年由双胞胎兄弟亚历克斯和迈克·法赫蒂以及亚历克斯的妻子克里·多彻蒂创立,是家族时尚和生活方式品牌,以冲浪风格和可持续工艺著称 [12] - 致力于社会影响和可持续发展,2024年秋季成为认证B公司和“1% for the Planet”成员 [12] - 在美国有78家门店,在700多个批发点销售,包括诺德斯特龙、Shopbop、布鲁明戴尔等 [12] - 官网为Faherty.com,联系邮箱为Faherty@jbc - pr.com [13] 联系方式 - 媒体联系邮箱:news@tilray.com [16] - 投资者关系联系邮箱:investors@tilray.com [16] - 公告配图链接:https://www.globenewswire.com/NewsRoom/AttachmentNg/66deb9b0 - dd31 - 4900 - b7bd - 36b7b85c4278 [16]
Pure Harvest Corporate Group Provides Corporate Update and Announces Significant Debt Reductions
Globenewswire· 2025-06-26 20:00
GREENWOOD VILLAGE, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Pure Harvest Corporate Group, Inc. (OTC: PHCG), a strategic holding company focused on acquiring and restructuring undervalued businesses, today provided a corporate update highlighting its continued progress in strengthening the Company’s balance sheet. As part of its ongoing restructuring efforts, Pure Harvest successfully settled $2,409,225 of outstanding debt obligations through the issuance of common stock at a fixed price of $0.10 per share. ...
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
Globenewswire· 2025-06-26 20:00
Hybrid, decentralized trial of bezisterim in early Parkinson’s Disease prioritizes patient access and participationCARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a poster highlighting the patient-centric design and accessibility of its ongoing SUNRISE-PD Phase 2 clinical t ...
Annovis to Attend the AAIC 2025 with Four Poster Presentations
Globenewswire· 2025-06-26 20:00
文章核心观点 - 安诺维斯生物公司高级管理层将参加2025年7月27 - 31日在加拿大多伦多举行的阿尔茨海默病协会国际会议,并展示四篇科学海报,突出其阿尔茨海默病临床项目进展和主要候选药物布坦奈他的药代动力学特征 [1] 公司动态 - 公司高级管理层将参加2025年7月27 - 31日在加拿大多伦多举行的阿尔茨海默病协会国际会议 [1] - 公司将展示四篇科学海报,分别为基于先前研究见解设计的布坦奈他治疗早期阿尔茨海默病患者的III期研究、布坦奈他治疗早期阿尔茨海默病患者的双6个月和18个月前瞻性随机安慰剂对照双盲关键临床试验、布坦奈他原始半结晶形式与新型结晶形式在动物和人类中的比较药代动力学特征、早期阿尔茨海默病和帕金森病患者血浆中布坦奈他的药代动力学特征 [1][2] 会议信息 - 2025年阿尔茨海默病协会国际会议是全球最大的致力于推进痴呆症科学和临床实践的会议 [3] - 每年会议汇聚全球研究人员、临床医生和专业人士,分享前沿发现和临床见解,旨在改善阿尔茨海默病和其他痴呆症患者的诊断、治疗和护理 [3] 公司介绍 - 公司总部位于宾夕法尼亚州马尔文,致力于解决阿尔茨海默病和帕金森病等神经退行性疾病问题 [4] - 公司致力于开发创新疗法,改善患者预后和生活质量 [4] 投资者提示 - 鼓励感兴趣的投资者和股东通过在https://www.annovisbio.com/email - alerts注册电子邮件提醒,获取新闻稿和行业更新 [5] 联系方式 - 公司地址为宾夕法尼亚州马尔文市林登伍德大道101号225室,网址为www.annovisbio.com [7] - 投资者联系人为战略传播总监Alexander Morin博士,邮箱为ir@annovisbio.com [7][8]
Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board
Globenewswire· 2025-06-26 20:00
文章核心观点 公司董事会任命Natalie Davis为董事会主席,接替自2017年起担任该职位的Craig McNally [1] 公司人事变动 - 董事会宣布任命Natalie Davis为董事会主席,Craig McNally卸任 [1] - 首席执行官Pascal Roché感谢Craig McNally八年的卓越贡献,欢迎Natalie Davis加入 [2] - Natalie Davis表示荣幸加入并期待为集团目标做贡献 [3] 新主席履历 - Natalie Davis毕业于INSEAD,拥有悉尼大学商业和法律双学位 [4] - 曾在麦肯锡公司担任15年合伙人,后加入伍尔沃斯集团,2024年任拉姆齐医疗保健首席执行官 [4] 公司概况 - 公司是欧洲私立住院和初级保健领域的领导者,有38000名员工和9300名从业者,服务1200万患者 [5] - 公司是使命驱动型企业,致力于通过创新改善人们健康,参与公共卫生服务任务 [6] - 公司每年在创新方面投资超2亿欧元,以支持护理途径的发展和多样化 [7] 公司联系方式 - 网站为www.ramsaysante.fr,还有Facebook、Instagram等社交账号 [8] - 媒体关系联系人是Brigitte Cachon,电话+33 1 87 86 22 11,邮箱brigitte.cachon@ramsaysante.fr [8]